The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksATMA.L Regulatory News (ATMA)

  • There is currently no data for ATMA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing and Open Offer

30 Aug 2017 15:46

RNS Number : 3434P
ATLAS Mara Limited
30 August 2017
 

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

30 August 2017

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

ATLAS MARA LIMITED

Results of Placing and Open Offer

Atlas Mara Limited ("Atlas Mara" or the "Company" and, together with its subsidiaries, the "Group") is pleased to announce the closing of the offer period for the recently launched Placing and the Open Offer on 29 August 2017. The Placing and Open Offer, together with the recently announced strategic investment from Fairfax Africa (comprising a Mandatory Convertible Bond and a Firm Placing) constitutes "the Strategic Financing". The Strategic Financing will support Atlas Mara's growth initiatives in the acquisition of additional equity interests in Union Bank of Nigeria Plc ("UBN") and scaling up the Markets and Treasury and Fintech business lines. Further terms of the Placing and Open Offer are set out in the Atlas Mara prospectus dated 10 August 2017 (the "Prospectus").

Under the Placing and Open Offer, the Company's existing shareholders have subscribed for 17,438,310 New Ordinary Shares in the capital of the Company. Fairfax Africa has accordingly subscribed for 13,672,801 New Ordinary Shares under the Placing and Open Offer. In combination with the New Ordinary Shares subscribed for by Fairfax Africa under the Strategic Financing, Fairfax Africa's shareholding in the capital of the Company will equal 71,728,356 ordinary Shares.

The New Ordinary Shares issued as a result of the Strategic Financing are expected to be admitted to trading on the Main Market of the London Stock Exchange PLC as a Standard Listing on 31 August 2017 at 8.00 a.m. The New Ordinary Shares will rank pari passu in all respects with the Existing Ordinary Shares.

Following admission of the New Ordinary Shares, the Company will have 172,258,735 ordinary shares in issue, of which 1,977,096 will continue to be held in treasury and 3,298,298 shares will continue to be held in escrow as part of the acquisition-related contingent consideration disclosed to the market on 1 July 2016.

Atlas Mara hereby confirms that the total number of voting rights in Atlas Mara will following Admission be 166,983,341. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Atlas Mara under the DTRs.

Bob Diamond, Chairman of the Board of Atlas Mara, said: "We are thrilled to have Fairfax Africa as our long-term partner. This transaction puts Atlas Mara in a very strong position to deliver on our strategic goals. We remain focused on execution and delivering on cost discipline and profitability."

 

Contact Details

InvestorsJohn-Paul Crutchley +971 4 275 6000 Kojo Dufu +1 212 883 4330

MediaTeneo Blue Rubicon, Anthony Silverman +44 20 3757 9231

Financial Advisers

Citigroup Global Markets Limited is acting as Financial Adviser and Corporate Broker to the Company.

About Atlas Mara

Atlas Mara Limited (ATMA.L) is a financial services institution listed on the London Stock Exchange. Its vision is to create sub-Saharan Africa's premier financial services institution through organic and inorganic growth by combining the best of global institutional knowledge with extensive local insights. With a presence in seven sub-Saharan countries, Atlas Mara aims to be a positive disruptive force in the markets in which we operate by leveraging technology to provide innovative and differentiated product offerings, excellent customer service and accelerate financial inclusion in the countries in which the Company operates. For more information, visit www.atlasmara.com. .

This announcement has been issued by and is the sole responsibility of Atlas Mara Limited.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRPMMITMBIJBIR
Date   Source Headline
28th Sep 20188:32 amRNSStatement re Management Changes
5th Sep 20187:51 amRNSAtlas Mara Limited 2018 Interim Results
30th Aug 20187:30 amRNSResults of AGM held on 29 August 2018
29th Aug 20186:16 pmRNSNotice of H1 2018 Results
7th Aug 20188:08 amRNSNotification of Major Interest in Shares
7th Aug 20187:53 amRNSNotice of AGM
6th Aug 20187:35 amRNSAtlas Mara Reaches Agreement on New Debt Facility
26th Jun 20187:56 amRNSStatement re Atlas Mara Increases Stake in UBN
7th Jun 20187:34 amRNSQ1 Interim Management Statement for 2018
2nd May 20187:09 amRNSVoting Rights & Director/PDMR Shareholding Update
24th Apr 20181:47 pmRNSReissued Atlas Mara Limited 2017 Year-End Results
24th Apr 20188:19 amRNSAtlas Mara Limited Announces 2017 Year-End Results
20th Apr 20187:00 amRNSNotice of Annual Results
29th Mar 20181:58 pmRNSTrading Update
28th Mar 20184:40 pmRNSSecond Price Monitoring Extn
28th Mar 20184:35 pmRNSPrice Monitoring Extension
1st Mar 20184:40 pmRNSSecond Price Monitoring Extn
1st Mar 20184:35 pmRNSPrice Monitoring Extension
15th Jan 20187:57 amRNSStatement re Atlas Mara Increases Stake in UBN
8th Jan 201812:07 pmRNSSecond Price Monitoring Extn
8th Jan 201812:02 pmRNSPrice Monitoring Extension
5th Jan 20186:19 pmRNSNotification of Major Interest in Shares
15th Dec 20174:40 pmRNSSecond Price Monitoring Extn
15th Dec 20174:35 pmRNSPrice Monitoring Extension
1st Dec 20174:40 pmRNSSecond Price Monitoring Extn
1st Dec 20174:35 pmRNSPrice Monitoring Extension
23rd Nov 20174:35 pmRNSPrice Monitoring Extension
8th Nov 201712:13 pmRNSQ3 Interim Management Statement for 2017
2nd Nov 20175:08 pmRNSNotice of Q3 2017 Results
3rd Oct 20177:59 amRNSDirectorate Change
18th Sep 20177:12 amRNSVoting Rights & Director/PDMR Shareholding Update
11th Sep 20177:28 amRNSNotification of Major Interest in Shares
8th Sep 20175:04 pmRNSNotification of Major Interest in Shares
8th Sep 20175:02 pmRNSNotification of Major Interest in Shares
8th Sep 20175:00 pmRNSNotification of Major Interest in Shares
7th Sep 20177:33 amRNSAtlas Mara Limited 2017 Interim Results
6th Sep 20175:50 pmRNSStatement re Conversion Price Adjustment of Bonds
5th Sep 20177:13 amRNSNotice of H1 2017 Results
1st Sep 20177:00 amRNSCompletion of Strategic Financing
30th Aug 20173:46 pmRNSResult of Placing and Open Offer
25th Aug 20174:40 pmRNSSecond Price Monitoring Extn
25th Aug 20174:35 pmRNSPrice Monitoring Extension
18th Aug 20174:15 pmRNSStatement re Cancellation of Expired Warrants
17th Aug 20174:40 pmRNSSecond Price Monitoring Extn
17th Aug 20174:35 pmRNSPrice Monitoring Extension
11th Aug 20177:05 amRNSPublication of Prospectus
10th Aug 201710:28 amRNSOpen Offer Ex-entitlement date - Clarification
9th Aug 20176:26 pmRNSEx-entitlement date for the Open Offer
9th Aug 20174:35 pmRNSPrice Monitoring Extension
8th Aug 20171:24 pmRNSStatement re Equity Offering Timetable

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.